PMC Articles for PubChem Compound (Select 5277135) - PMC

Inès Devred, Kick Kayembe, Nadia Valin, Hayette Rougier, Bruce Wuembulua Shinga, Sidonie Lambert-Niclot, Thibault Chiarabini, Marie-Caroline Meyohas, Karine Lacombe

BMC Infect Dis. 2023; 23: 578. Published online 2023 Sep 4. doi: 10.1186/s12879-023-08544-x

PMCID:: PMC10478445

Abstract Article PDF–1.0M

Select item 103597844.

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

Sandra Rotea-Salvo, Alejandro Martínez-Pradeda, Carla Fernández-Oliveira, Victor Giménez-Arufe, Vanesa Balboa-Barreiro, Luis Margusino-Framiñán, Álvaro Mena-De-Cea, Pilar Vázquez-Rodríguez, Ángeles Castro-Iglesias, Soledad López-Calvo, Isabel Martín-Herranz, Enrique Míguez-Rey, Purificación Cid-Silva

Eur J Hosp Pharm. 2023 Jul; 30(4): 221–226. Published online 2021 Oct 14. doi: 10.1136/ejhpharm-2021-002896

PMCID:: PMC10359784

Abstract Article PDF–293K

Select item 102697615.

Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients

Yu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, Shu-Hsing Cheng, Po-Liang Lu, Chen-Hsiang Lee, Yuan-Ti Lee, Hung-Chin Tsai, Chia-Jui Yang, Chun-Eng Liu, Bo-Huang Liou, Shih-Ping Lin, Sung-Hsi Huang, Mao-Wang Ho, Hung-Jen Tang, Chien-Ching Hung, on behalf of the Taiwan HIV Study Group

Microbiol Spectr. 2023 May-Jun; 11(3): e05125-22. Published online 2023 Mar 29. doi: 10.1128/spectrum.05125-22

PMCID:: PMC10269761

Abstract Article PDF–1.1M

Select item 101546076.

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir

Andrea R. Thurman, Louise A. Ouattara, Nazita Yousefieh, Peter L. Anderson, Lane R. Bushman, Xi Fang, Homaira Hanif, Meredith Clark, Onkar Singh, Gustavo F. Doncel

Front Cell Infect Microbiol. 2023; 13: 1130101. Published online 2023 Apr 19. doi: 10.3389/fcimb.2023.1130101

PMCID:: PMC10154607

Abstract Article PDF–2.3M

Select item 99452517.

Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome

Lina Fan, Lei Li, Liying Gao, Yue Hu, Aiping Yu, Defa Zhang, Chunting Qiu, Rong Huang, Yue Wu, Ping Ma

Chin Med J (Engl) 2022 Nov 20; 135(22): 2747–2749. Published online 2022 Dec 27. doi: 10.1097/CM9.0000000000002503

PMCID:: PMC9945251

Article PDF–1.3M

Select item 99101068.

EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water

Adriana Andrade, Edward J. Fuchs, Mark A. Marzinke, Sandra Abdul Massih, Jennifer Breakey, Sasha Beselman, Ian McNicholl, Craig W. Hendrix

AIDS Res Hum Retroviruses. January 2023; 39(1): 38–43. Published online 2023 Jan 11. doi: 10.1089/aid.2022.0085

PMCID:: PMC9910106

Abstract Article PDF–556K

Select item 98091229.

Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study

Nathalie De Castro, Alexandre Brun, Pierre Sellier, Gwenn Hamet, Frédéric Mechaï, Valérie Garrait, Amélie Chabrol, Marie-Anne Bouldouyre, Eric Froguel, Didier Troisvallets, Pauline Caraux-Paz, Constance Delaugerre, Willy Rozenbaum, Jean-Michel Molina

AIDS Res Ther. 2023; 20: 1. Published online 2023 Jan 3. doi: 10.1186/s12981-022-00499-4

PMCID:: PMC9809122

Abstract Article PDF–641K

Select item 974412410.

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States

Kunjal Patel, Yanling Huo, Jennifer Jao, Kathleen M. Powis, Paige L. Williams, Deborah Kacanek, Lynn M. Yee, Ellen G. Chadwick, Stephanie Shiau, Denise L. Jacobson, Sean S. Brummel, Leila Sultan-Beyer, Christian R. Kahlert, Rebecca Zash, George R. Seage, III, Pediatric HIV/AIDS Cohort Study and the Swiss Mother and Child HIV Cohort Study

N Engl J Med. Author manuscript; available in PMC 2023 Mar 1.

Published in final edited form as: N Engl J Med. 2022 Sep 1; 387(9): 799–809. doi: 10.1056/NEJMoa2200600

PMCID:: PMC9744124

Abstract Article PDF–773K

Select item 969190911.

Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques

Charles W. Dobard, M. Melissa Peet, Kenji Nishiura, Angela Holder, Chuong Dinh, James Mitchell, George Khalil, Yi Pan, Onkar N. Singh, Timothy J. McCormick, Vivek Agrahari, Pardeep Gupta, Sriramakamal Jonnalagadda, Walid Heneine, Meredith R. Clark, J. Gerardo García-Lerma, Gustavo F. Doncel

eBioMedicine. 2022 Dec; 86: 104361. Published online 2022 Nov 21. doi: 10.1016/j.ebiom.2022.104361

PMCID:: PMC9691909

Abstract Article PDF–705K

Select item 964340112.

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques

Natalia Makarova, Tyana Singletary, M. Melissa Peet, James Mitchell, Angela Holder, Chuong Dinh, Vivek Agrahari, Maria Mendoza, Yi Pan, Walid Heneine, Meredith R. Clark, J. Gerardo García-Lerma, James M. Smith, Gustavo F. Doncel

eBioMedicine. 2022 Dec; 86: 104338. Published online 2022 Nov 5. doi: 10.1016/j.ebiom.2022.104338

PMCID:: PMC9643401

Abstract Article PDF–705K

Select item 888981213.

Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting

Bilgul Mete, Alper Gunduz, Hayat Kumbasar Karaosmanoglu, Fatma Gumuser, Sibel Bolukcu, Dilek Sevgi Yildiz, Ozlem Altuntas Aydin, Bilgenur Bilge, Ilyas Dokmetas, Fehmi Tabak

Afr Health Sci. 2021 Dec; 21(4): 1593–1602. doi: 10.4314/ahs.v21i4.13

PMCID:: PMC8889812

Abstract Article PDF–509K

Select item 878361914.

Dolutegravir Impairs Stem Cell-Based 3D Morphogenesis Models in a Manner Dependent on Dose and Timing of Exposure: An Implication for Its Developmental Toxicity

Lauren Kirkwood-Johnson, Nana Katayama, Yusuke Marikawa

Toxicol Sci. 2021 Dec; 184(2): 191–203. Published online 2021 Sep 13. doi: 10.1093/toxsci/kfab112

PMCID:: PMC8783619

Abstract Article PDF–1.0M

Select item 866798015.

Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV

Huan Xia, Xiao-Jie Huang, Yue Hu, Li-Ying Gao, Yue Wu, Hao Wu, Zhong-Fang Yan, Ping Ma

Chin Med J (Engl) 2021 Dec 5; 134(23): 2850–2856. Published online 2021 Oct 13. doi: 10.1097/CM9.0000000000001824

PMCID:: PMC8667980

Abstract Article PDF–351K

Select item 851388916.

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort

Emanuele Focà, Andrea Calcagno, Stefano Calza, Stefano Renzetti, Annacarla Chiesa, Matteo Siano, Giuseppe De Socio, Stefania Piconi, Giancarlo Orofino, Giordano Madeddu, Anna Maria Cattelan, Silvia Nozza, Micol Ferrara, Jovana Milic, Benedetto Maurizio Celesia, Francesco Castelli, Giovanni Guaraldi

PLoS One. 2021; 16(10): e0258533. Published online 2021 Oct 13. doi: 10.1371/journal.pone.0258533

PMCID:: PMC8513889

Abstract Article PDF–601K

Select item 831992017.

Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women with HIV

Jane A O’Halloran, Kunbo Wang, Amanda B. Spence, Dionna W. Williams, Raha Dastgheyb, Kathryn C. Fitzgerald, Asante R. Kamkwalala, Pauline M. Maki, Anjali Sharma, Deborah R. Gustafson, Joel Milam, Kathleen M. Weber, Adaora A. Adimora, Igho Ofotokun, Margaret A. Fischl, Deborah Konkle-Parker, Cecile D. Lahiri, Anandi N. Sheth, Yanxun Xu, Leah H. Rubin

J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2021 Jul 29.

Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Apr 15; 86(5): 593–599. doi: 10.1097/QAI.0000000000002608

PMCID:: PMC8319920

Abstract Article PDF–472K

Select item 789921518.

Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation

Ignacio Perez-Valero, Josep M. Llibre, Antonella Castagna, Federico Pulido, Jean-Michel Molina, Stefan Esser, Nicolas Margot, Yongwu Shao, Lauren Temme, David Piontkowsky, Ian R. McNicholl, Richard Haubrich

J Acquir Immune Defic Syndr. 2021 Apr 1; 86(4): 490–495. Published online 2020 Dec 10. doi: 10.1097/QAI.0000000000002595

PMCID:: PMC7899215

Abstract Article PDF–289K

Select item 774497419.

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network

Vera Bukkems, Coca Necsoi, Carmen Hidalgo Tenorio, Coral Garcia, Jürgen Rockstroh, Caroline Schwarze-Zander, John S Lambert, David Burger, Deborah Konopnicki, Angela Colbers

Clin Infect Dis. 2020 Nov 15; 71(10): e714–e717. Published online 2020 Apr 24. doi: 10.1093/cid/ciaa488

PMCID:: PMC7744974

Abstract Article PDF–122K

Select item 773654920.

Differential effects of integrase strand transfer inhibitors, elvitegravir and raltegravir, on oligodendrocyte maturation: a role for the integrated stress response

Lindsay M. Roth, Bassam Zidane, Lindsay Festa, Raj Putatunda, Micah Romer, Hubert Monnerie, Kelly L. Jordan-Sciutto, Judith B. Grinspan

Glia. Author manuscript; available in PMC 2022 Feb 1.

Published in final edited form as: Glia. 2021 Feb; 69(2): 362–376. Published online 2020 Sep 7. doi: 10.1002/glia.23902

PMCID:: PMC7736549

Abstract Article PDF–4.0M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from PubChem Compound

Items: 1 to 20 of 179

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity